Drug Profile
EBI 031
Alternative Names: EBI-031Latest Information Update: 08 Mar 2023
Price :
$50
*
At a glance
- Originator Sesen Bio
- Developer Carisma Therapeutics
- Class Anti-inflammatories; Eye disorder therapies; Monoclonal antibodies; Proteins
- Mechanism of Action Interleukin 6 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Diabetic macular oedema